BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37768244)

  • 1. Natriuretic Peptide Normative Levels and Deficiency: The National Health and Nutrition Examination Survey.
    Shetty NS; Patel N; Gaonkar M; Li P; Arora G; Arora P
    JACC Heart Fail; 2024 Jan; 12(1):50-63. PubMed ID: 37768244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial Differences in Natriuretic Peptide Levels: The Dallas Heart Study.
    Gupta DK; de Lemos JA; Ayers CR; Berry JD; Wang TJ
    JACC Heart Fail; 2015 Jul; 3(7):513-519. PubMed ID: 26071618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in Natriuretic Peptide Levels by Race/Ethnicity (From the Multi-Ethnic Study of Atherosclerosis).
    Gupta DK; Daniels LB; Cheng S; deFilippi CR; Criqui MH; Maisel AS; Lima JA; Bahrami H; Greenland P; Cushman M; Tracy R; Siscovick D; Bertoni AG; Cannone V; Burnett JC; Carr JJ; Wang TJ
    Am J Cardiol; 2017 Sep; 120(6):1008-1015. PubMed ID: 28750825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Race-based demographic, anthropometric and clinical correlates of N-terminal-pro B-type natriuretic peptide.
    Patel N; Gutiérrez OM; Arora G; Howard G; Howard VJ; Judd SE; Prabhu SD; Levitan EB; Cushman M; Arora P
    Int J Cardiol; 2019 Jul; 286():145-151. PubMed ID: 30878238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex-specific associations of obesity and N-terminal pro-B-type natriuretic peptide levels in the general population.
    Suthahar N; Meijers WC; Ho JE; Gansevoort RT; Voors AA; van der Meer P; Bakker SJL; Heymans S; van Empel V; Schroen B; van der Harst P; van Veldhuisen DJ; de Boer RA
    Eur J Heart Fail; 2018 Aug; 20(8):1205-1214. PubMed ID: 29855124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex and Race Differences in N-Terminal Pro-B-type Natriuretic Peptide Concentration and Absolute Risk of Heart Failure in the Community.
    Myhre PL; Claggett B; Yu B; Skali H; Solomon SD; Røsjø H; Omland T; Wiggins KL; Psaty BM; Floyd JS; Selvin E; Ballantyne CM; Shah AM
    JAMA Cardiol; 2022 Jun; 7(6):623-631. PubMed ID: 35476049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NT-proBNP and All-Cause and Cardiovascular Mortality in US Adults: A Prospective Cohort Study.
    Echouffo-Tcheugui JB; Zhang S; Daya N; McEvoy JW; Tang O; Juraschek SP; Ndumele CE; Coresh J; Christenson RH; Selvin E
    J Am Heart Assoc; 2023 Jun; 12(11):e029110. PubMed ID: 37232235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Associations of A-/B-Type Natriuretic Peptides With Cardiac Structure, Function, and Prognosis in Heart Failure.
    Tan ESJ; Chan SP; Liew OW; Chong JPC; Gerard Leong KT; Daniel Yeo PS; Ong HY; Jaufeerally F; Sim D; Ling LH; Lam CSP; Richards AM
    JACC Heart Fail; 2024 Mar; 12(3):461-474. PubMed ID: 37897459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial/ethnic differences in circulating natriuretic peptide levels: The Diabetes Prevention Program.
    Gupta DK; Walford GA; Ma Y; Jarolim P; Wang TJ;
    PLoS One; 2020; 15(2):e0229280. PubMed ID: 32084251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reference Ranges for NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and Risk Factors for Higher NT-proBNP Concentrations in a Large General Population Cohort.
    Welsh P; Campbell RT; Mooney L; Kimenai DM; Hayward C; Campbell A; Porteous D; Mills NL; Lang NN; Petrie MC; Januzzi JL; McMurray JJV; Sattar N
    Circ Heart Fail; 2022 Oct; 15(10):e009427. PubMed ID: 36098049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diurnal Variations in Natriuretic Peptide Levels: Clinical Implications for the Diagnosis of Acute Heart Failure.
    Breidthardt T; van Doorn WPTM; van der Linden N; Diebold M; Wussler D; Danier I; Zimmermann T; Shrestha S; Kozhuharov N; Belkin M; Porta C; Strebel I; Michou E; Gualandro DM; Nowak A; Meex SJR; Mueller C
    Circ Heart Fail; 2022 Jun; 15(6):e009165. PubMed ID: 35670217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease.
    Hess G; Runkel S; Zdunek D; Hitzler WE
    Clin Lab; 2005; 51(3-4):167-72. PubMed ID: 15819172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NT-proBNP, race and endothelial function in the Multi-Ethnic Study of Atherosclerosis.
    Yang S; Huang S; Daniels LB; Yeboah J; Lima JAC; Cannone V; Burnett JC; Beckman JA; Carr JJ; Wang TJ; Gupta DK
    Heart; 2019 Oct; 105(20):1590-1596. PubMed ID: 31152069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial measurement of N-terminal pro-B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Daniels LB; Clopton P; deFilippi CR; Sanchez OA; Bahrami H; Lima JA; Tracy RP; Siscovick D; Bertoni AG; Greenland P; Cushman M; Maisel AS; Criqui MH
    Am Heart J; 2015 Dec; 170(6):1170-83. PubMed ID: 26678639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NT-proBNP Reference Intervals in Healthy U.S. Children, Adolescents, and Adults.
    Mu S; Echouffo-Tcheugui JB; Ndumele CE; Coresh J; Juraschek S; Brady T; McEvoy JW; Ozkan B; Tang O; Christenson RH; Selvin E
    J Appl Lab Med; 2023 Jul; 8(4):700-712. PubMed ID: 37279581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial differences in the association of NT-proBNP with risk of incident heart failure in REGARDS.
    Patel N; Cushman M; Gutiérrez OM; Howard G; Safford MM; Muntner P; Durant RW; Prabhu SD; Arora G; Levitan EB; Arora P
    JCI Insight; 2019 Jun; 5(13):. PubMed ID: 31162140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronobiology of Natriuretic Peptides and Blood Pressure in Lean and Obese Individuals.
    Parcha V; Patel N; Gutierrez OM; Li P; Gamble KL; Musunuru K; Margulies KB; Cappola TP; Wang TJ; Arora G; Arora P
    J Am Coll Cardiol; 2021 May; 77(18):2291-2303. PubMed ID: 33958126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial and ethnic differences in circulating N-terminal pro-brain-type natriuretic peptide (NT-proBNP) in US adults.
    Commodore-Mensah Y; Wang D; Jeon Y; Foti K; McEvoy JW; Coresh J; Tang O; Echouffo-Tcheugui JB; Christenson R; Ndumele CE; Selvin E
    Am J Prev Cardiol; 2023 Sep; 15():100526. PubMed ID: 37560479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Terminal Pro Brain, N-Terminal Pro Atrial Natriuretic Peptides, and Dynamic Cerebral Autoregulation.
    Mahinrad S; Sabayan B; Garner CR; Lloyd-Jones DM; Sorond FA
    J Am Heart Assoc; 2020 Oct; 9(20):e018203. PubMed ID: 33059537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal association between N-terminal B-type natriuretic peptide, anxiety and social support in patients with HFpEF: results from the multicentre randomized controlled Aldo-DHF trial.
    Wilke MR; Broschmann D; Sandek A; Wachter R; Edelmann F; Herrmann-Lingen C
    BMC Cardiovasc Disord; 2023 Apr; 23(1):184. PubMed ID: 37020188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.